MDSpire - Takeaway
From the Journals

Metabolic Acidosis Care Limited in Chronic Kidney Disease

Low testing rates may contribute to underdiagnosis and undertreatment in Japan

Share

  • 1

    Metabolic acidosis affects 44% of CKD patients in Japan.

  • 2

    Prevalence increases with CKD stage: G3a (32%), G3b (46%), G4 (66%).

  • 3

    Only 9% of patients with acidosis received a diagnosis.

  • 4

    Treatment rates were also low: 8% overall.

  • 5

    Patients tested were typically older and had advanced CKD.

  • 6

    Importance of improving clinical management of metabolic acidosis is highlighted.

  • 7

    Limitations include reliance on serum bicarbonate without pH measurement.

Original Source(s)

Metabolic Acidosis Care Limited in Chronic Kidney Disease

  • by Matthew Solan

  • March 23, 2026

Related Content

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

The Past, Present and Future of Non-Target Screening

Thomas Letzel reflects on the evolution of non-target screening and why interdisciplinary insights are key to its future

  • March 23, 2026

  • 9 min
From Crisis to Compliance: Navigating Europe’s Toughest Medical Device Rules

Compliance is no longer a background function — it is central to maintaining access